# VAIXLNS Ω∞ — Evidence Closure Engineering Execution Plan

**Document ID:** VAIXLNS.EVIDENCE.CLOSURE.PLAN.2026-10-25  
**Date:** 2026-10-25  
**Status:** PROPOSED / SIMULATED / NOT EXECUTED  
**Owner boundary:** VAIXLNS Governance / Ω.000, with independent VV/AEPF review and bounded VX execution.  
**Canonical anchors:** `project.genome::v1.0.0`, `Ω0_GENESIS_CORE`, `Ω.000`.  
**Safety:** No autonomous canonical promotion, production write, historical deletion, or substitution of simulated evidence for observed tests.

## Verified inventory and scope
The repository-generated `registry/innovation-operation-index.v1.json` was read on 2026-10-25: 177 innovation operation records; 22 have nonempty `evidence_refs`, 155 are empty. The source index has 174 records marked for manual review and 66 status UNKNOWN. These counts describe links and source claims, **not implementation or verification**. Historical ~0001–2750 recovery is explicitly outside this closure target. Initial Git blob SHA for index: `b02f6fd0bd827273b67948a566946eab3160fd6d`; pin a full commit before production runs.

**User-selected simulation assumptions:** 155 accessible evidence sources (100% availability), net throughput of 40 *accepted* records per week; four weeks at batches 40/40/40/35. Starting linked coverage 22/177 (12.43%); projected completion 177/177 *only if* all new references are independently valid for their explicitly limited claim scopes and the 22 preexisting references are audited.

| Batch | New accepted | Total with reference | Coverage |
|---|---:|---:|---:|
| Baseline | 0 | 22 | 12.4% |
| W1 | 40 | 62 | 35.0% |
| W2 | 40 | 102 | 57.6% |
| W3 | 40 | 142 | 80.2% |
| W4 | 35 | 177 | 100.0% |

## Engineering integration: extend existing indexers
```text
Pinned authorized sources and approved archives
  -> VAIXLNS Zero-Loss Index (existing 28 views)
  -> 155-record candidate queue + independent review of 22 existing links
  -> source pin / digest / access validation / claim scope
  -> VV-AEPF evidence challenge + contradictions / independent falsifiers
  -> curated source catalogs and registry/innovation-operation-profiles.v1.json
  -> tools/build_innovation_operation_index.py
  -> tools/validate_innovation_operation_index.py
  -> PR / CI / two-run deterministic replay
  -> VAIXLNS governance decision (separate from proof)
  -> indexed receipts / coverage / expiry monitoring
```
The generated `registry/innovation-operation-index.v1.json` and `docs/innovation/INNOVATION_OPERATION_INDEX.md` must not be edited by hand. The historical `Ω.000` manifest and `project.genome` remain unchanged by this proposal. `source_refs` must not be silently converted to `evidence_refs`; source references alone do not establish proof. An unavailable source is BLOCKED_SOURCE_UNAVAILABLE, never replaced with fabricated evidence.

## Acceptance metrics
- KPI-A: linked evidence coverage = accepted valid source-backed references / 177, target 177/177 (requires separately reviewing the initial 22).
- KPI-B: claim-support accuracy = independently reviewed references correctly classified by scope (e.g. SPECIFICATION_EXISTS, IMPLEMENTATION_EXISTS, TEST_PASSED), target 100% for accepted references.
- KPI-C: provenance = references with immutable source identity, access check, digest/ref, reviewer and evidence receipt / accepted references; target 100%.
- Guards: zero leaked secrets; zero unauthorized canonical promotion; zero missing mandatory tests represented as PASS; conflicts retained rather than overwritten.

## Six mandatory proof gates
| Gate | Required evidence | Fail state |
|---|---|---|
| G0 Baseline | Recompute 177, 22, 155 from pinned source revision; log SHA and access boundary | HOLD |
| G1 Source integrity | Authorized readable pinned source, origin, location and digest | BLOCKED / QUARANTINED |
| G2 Reference coverage | All 155 linked and original 22 audited with claim-scoped references | PARTIAL until 177/177 |
| G3 Independent review | Claim/evidence mapping, contradiction screen, reviewer not sole producer | HOLD |
| G4 Deterministic generation | Builder and validator pass; two rebuilds same input give matching content hashes | BLOCKED |
| G5-G6 Admission + sustainment | Human-authorized PR, rollback, evidence expiry and monitoring | NOT_ADMITTED |

Do not infer implementation or readiness from a successful index build, a CI-green label, or architectural prose.

## Risks and mitigations
- Missing original sources: at 90% availability, ~16 of 155 remain blocked; even if 139 are recovered, linked coverage is 161/177 = 90.96%, *not* 100%. Report unresolved sources and seek authorized recovery.
- Review rework: first-pass acceptance 85% reduces throughput to floor(40*0.85)=34/wk; 155 entries require 5 weeks. To maintain 40 accepted per week plan at least 48 attempts per week (floor(48*0.85)=40).
- Disputed identity/duplicates: preserve every source, all aliases and full provenance; use identity-conflict queue, not destructive merges.
- Secret/private-source leakage: connector-scoped read-only permissions, secret scan, no copying private material to public index/build logs; opaque hashes where appropriate.
- Test/proof overclaiming: keep SOURCE / ATOMIC / IMPLEMENTED / VERIFIED separate and require executable receipts for higher states.
- CI or worker outage: persist checkpoint receipts, retry idempotently, isolate failure, block final promotion.
- Scope expansion: historic 2750 legacy range and live external adapters are separate backlogs, not implicit deliverables.

## Planning costs (illustrative SAR; not supplier quotes or commitments)
Assume baseline fixed startup SAR 12,000, team/run costs SAR 21,700 per active week, 15% contingency:
- Ideal 4 weeks: (12,000 + 4×21,700)×1.15 = **SAR 113,620**.
- 15% rework / 5 weeks: (12,000 + 5×21,700)×1.15 = **SAR 138,575**.
- 40% rework + one additional paid interruption week / 8 chargeable weeks: (12,000 + 8×21,700)×1.15 = **SAR 213,440**.
- Accelerated 48 attempted per week with ~85% acceptance and enhanced weekly cost SAR 25,860: (12,000 + 4×25,860)×1.15 = **SAR 132,756**.

Budget excludes tax, new licensed connectors/services, and unknown source-acquisition expenses. Scenario 90% source availability cannot close the 16 blocked items just by paying for more review weeks.

## Sequencing / control
**Pilot:** independently review 8–10 varied records and all status categories represented; measure first-pass acceptance, minutes per receipt, provenance completeness, and review disagreement before committing the full 4-week target.

**W1:** source capture and 40 accepted receipts; **W2:** 40 accepted; **W3:** 40 accepted; **W4:** final 35 and 22-item legacy reference audit. Weekly reports track accepted, rejected, blocked, independently verified, revision-pinned coverage, source-access blockers and spend.

**Decision:** GO only after pilot establishes enough source accessibility, permissions, team throughput and reviewer independence; else revise baseline and timeline. This document is **indexed planning material**, not evidence the rollout occurred.

## Links to existing source-of-truth
- [Zero-Loss contract](../indexes/VAIXLNS_ZERO_LOSS_INDEX_V1.md)
- [Innovation master index](../indexes/INNOVATION_MASTER_INDEX.md)
- [Innovation operation index](../innovation/INNOVATION_OPERATION_INDEX.md)
- [Source profile registry](../../registry/innovation-operation-profiles.v1.json)
- [Engineering proof fabric](../architecture/AEPF_ADVERSARIAL_ENGINEERING_AND_PROOF_FABRIC_V1.md)
- [October recovery audit](../recovery/VAIXLNS_UNIFIED_INNOVATION_DELIVERY_MAP_2026-10-10.md)
- [Scenario calculation model](../../tools/evidence_closure_scenario.py)
